Earnings Ahead

PIRS - Pieris Pharmaceuticals

Pieris Pharmaceuticals

Pieris Pharmaceuticals

About

Profile


Headquarters

Boston, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

PIRS



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Pieris stock slumps ~15% after FY22 sees fall in revenue
  • Pieris Pharmaceuticals GAAP EPS of -$0.45 beats by $0.02, revenue of $25.9M misses by $0.67M
  • Pieris Pharmaceuticals Q4 2022 Earnings Preview
  • Pieris to get $5M as Seagen starts dosing in phase 1 trial of cancer drug
  • Pieris Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $5.37M beats by $0.86M
  • Pieris Pharma stock falls ~7% on Q2 earnings miss, discontinuation of a phase 2 study
  • Pieris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.03, revenue of $3.7M misses by $6.77M
  • Pieris Pharmaceuticals Q2 2022 Earnings Preview
  • Pieris Pharmaceuticals GAAP EPS of -$0.07 beats by $0.05, revenue of $10.99M misses by $0.31M
  • Pieris Pharmaceuticals Q1 2022 Earnings Preview
  • Pieris Pharmaceuticals GAAP EPS of -$0.71 beats by $0.17, revenue of $31.41M beats by $5.97M
  • Pieris Pharmaceuticals Q4 2021 Earnings Preview
  • Pieris Pharmaceuticals begins dosing in phase 2 gastric cancer study
  • Pieris Pharmaceuticals EPS in-line, misses on revenue
  • Pieris Pharmaceuticals promotes from within for CFO position
  • Pieris Pharmaceuticals EPS beats by $0.02, beats on revenue
  • Jefferies boosts price target for Pieris citing plans to develop 'long COVID' candidate
  • Pieris Pharma stock soars 17% on development plans for PRS-220 in lung disease; secures $17M grant
  • Kaleido Biosciences, Pieris Pharmaceuticals leads healthcare gainers; Portage Biotech, Rite Aid among major losers
  • Pieris Pharmaceuticals shares rise after FDA orphan drug status for cinrebafusp
Date Price Open High Low Vol Change ER
May 26, 2023 0.75 0.84
0.88
0.75
758K -8.54%
May 25, 2023 0.82 0.88
0.88
0.82
532K -7.87%
May 24, 2023 0.89 0.93
0.93
0.87
121K -4.3%
May 23, 2023 0.93 0.94
0.97
0.89
1.3M 6.90%
May 22, 2023 0.87 0.83
0.87
0.8
401K 6.10%
 
May 19, 2023 0.82 0.88
0.92
0.8
334K -4.65%
May 18, 2023 0.86 0.83
0.96
0.83
2.2M 7.50%
May 17, 2023 0.8 0.8
0.81
0.76
279K 0%
May 16, 2023 0.8 0.84
0.85
0.79
132K -6.98%
May 15, 2023 0.86 0.86
0.9
0.8
1.4M 0%
May 12, 2023 0.86 0.95
0.95
0.85
195K -9.47%
May 11, 2023 0.95 0.85
0.99
0.79
13.3M 10.47%
May 10, 2023 0.86 0.83
0.87
0.78
218K 1.18%
May 9, 2023 0.85 0.82
0.85
0.76
210K 3.66%
May 8, 2023 0.82 0.84
0.87
0.81
142K -4.65%
May 5, 2023 0.86 0.81
0.87
0.79
170K 7.50%
May 4, 2023 0.8 0.82
0.87
0.77
299K -2.44%
May 3, 2023 0.82 0.78
0.85
0.74
7.9M 6.49%
May 2, 2023 0.77 0.73
0.77
0.73
116K 4.05%
May 1, 2023 0.74 0.76
0.77
0.72
755K -2.63%
Apr 28, 2023 0.76 0.76
0.82
0.73
196K -1.3%
Apr 27, 2023 0.77 0.78
0.81
0.76
172K -1.28%
Apr 26, 2023 0.78 0.8
0.82
0.77
194K -2.5%
Apr 25, 2023 0.8 0.84
0.87
0.8
203K -8.05%
Apr 24, 2023 0.87 0.8
0.91
0.76
372K 8.75%
Apr 21, 2023 0.8 0.85
0.85
0.75
335K -3.61%
Apr 20, 2023 0.83 0.85
0.85
0.8
200K 0%
Apr 19, 2023 0.83 0.84
0.85
0.8
474K 1.22%
Apr 18, 2023 0.82 0.81
0.84
0.77
390K 0%
Apr 17, 2023 0.82 0.79
0.83
0.77
811K 13.89%
Apr 14, 2023 0.72 0.76
0.77
0.72
108K -2.7%
Apr 13, 2023 0.74 0.75
0.77
0.73
341K -1.33%
Apr 12, 2023 0.75 0.77
0.77
0.75
230K -1.32%
Apr 11, 2023 0.76 0.79
0.8
0.76
161K -3.8%
Apr 10, 2023 0.79 0.79
0.83
0.75
207K 1.28%
Apr 6, 2023 0.78 0.87
0.88
0.77
591K -11.36%
Apr 5, 2023 0.88 0.9
0.94
0.87
170K -3.3%
Apr 4, 2023 0.91 0.97
1
0.9
185K -7.14%
Apr 3, 2023 0.98 1
1
0.96
390K 0%
Mar 31, 2023 0.98 1.03
1.04
0.97
288K -4.85%
Mar 30, 2023 1.03 1.02
1.12
1
555K -2.83%
Mar 29, 2023 1.06 1.1
1.29
0.95
1.5M -28.38%
Mar 28, 2023 1.48 1.34
1.52
1.26
308K 13.85%
Mar 27, 2023 1.3 1.23
1.36
1.23
155K 3.17%
Mar 24, 2023 1.26 1.2
1.27
1.13
165K 2.44%
Mar 23, 2023 1.23 1.29
1.39
1.19
102K 0.82%
Mar 22, 2023 1.22 1.3
1.36
1.22
74.7K -6.15%
Mar 21, 2023 1.3 1.2
1.35
1.19
153K 7.44%
Mar 20, 2023 1.21 1.21
1.23
1.15
92.3K 0%
Mar 17, 2023 1.21 1.33
1.38
1.21
211K -12.95%
Mar 16, 2023 1.39 1.43
1.45
1.37
42.3K -4.79%
Mar 15, 2023 1.46 1.39
1.51
1.35
67.3K 3.55%
Mar 14, 2023 1.41 1.43
1.47
1.4
109K 0.71%
Mar 13, 2023 1.4 1.28
1.44
1.28
92.1K 7.69%
Mar 10, 2023 1.3 1.33
1.35
1.25
127K -2.26%
Mar 9, 2023 1.33 1.48
1.51
1.3
205K -11.33%
Mar 8, 2023 1.5 1.48
1.5
1.4
107K 3.45%
Mar 7, 2023 1.45 1.44
1.47
1.42
56.1K 0.69%
Mar 6, 2023 1.44 1.46
1.46
1.4
99.0K -1.37%
Mar 3, 2023 1.46 1.47
1.48
1.41
104K 0%